Introduction
============

It has previously been reported that elevated triglyceride levels are a major risk factor for residual cardiovascular diseases (CVDs) ([@b1-etm-0-0-7269]). Hypertriglyceridemia is a common issue worldwide ([@b2-etm-0-0-7269]), and great attention has been given to identifying an appropriate treatment. Palmitic acid (PA), a major component of triglyceride in the blood ([@b3-etm-0-0-7269]), has been reported to induce cell dysfunction and death, particularly in nonadipose tissue cells, including pancreatic β cells, cardiomyocytes and hepatocytes ([@b4-etm-0-0-7269]). The lipotoxic effect of PA has been implicated in the pathogenesis of numerous CVDs ([@b5-etm-0-0-7269]). In addition, endothelial cells are important cellular components of the cardiovascular system, and therefore endothelial dysfunction is usually one of the early signs of CVD ([@b6-etm-0-0-7269]).

It is generally accepted that PA-induced cell death can occur due to increased reactive oxygen species (ROS) generation. A study recently reported that PA also serves an important role in the initiation of autophagy ([@b7-etm-0-0-7269]). ROS and autophagy have been linked to a number of pathophysiological mechanisms, and ROS at physiological concentrations are known to regulate redox homeostasis and kinase-driven signaling pathways ([@b8-etm-0-0-7269]). However, excessive ROS accumulation leads to oxidative stress that contributes to various malignancies and disorders ([@b9-etm-0-0-7269]). Macroautophagy, commonly known as autophagy, typically serves as a cell survival mechanism, although it can result in type II programmed cell death under certain conditions ([@b10-etm-0-0-7269]). Intracellular ROS are primarily generated as by-products in mitochondria ([@b11-etm-0-0-7269]). Certain enzymes, including nicotinamide adenine dinucleotide phosphate oxidases (NOXs), xanthine oxidase, endoplasmic reticulum oxidoreductase 1 and myeloperoxidase, as well as a number of organelles, including peroxisomes, are important sources of ROS generation ([@b12-etm-0-0-7269],[@b13-etm-0-0-7269]). As reported previously, excess ROS generation enhances autophagic activity via multiple pathways, which in turn degrades impaired mitochondria to restore normal ROS levels ([@b14-etm-0-0-7269]). However, exorbitant autophagy results in lysosomal dysfunction and endoplasmic reticulum stress ([@b15-etm-0-0-7269]). Although autophagy inhibition decreases ROS levels, the mechanism underlying this phenomenon remains to be elucidated ([@b16-etm-0-0-7269]).

The aim of the present study was to investigate the causal association between autophagy activation and ROS generation following PA treatment, as well as the molecular mechanism responsible for this effect in endothelial cells. The results revealed that PA-induced lipotoxicity is associated with autophagy activation, which enhances ROS generation via activating the calcium ion/protein kinase Cα/nicotinamide adenine dinucleotide phosphate oxidase 4 (Ca^2+^/PKCα/NOX4) pathway in endothelial cells. These results provide an insight into the potential of treating CVD by targeting autophagy.

Materials and methods
=====================

### Cell culture

Human umbilical vein endothelial cells (HUVECs) at passage 20 and 25 were used in all experiments (ATCC, Manassas, VA, USA). Cells were grown in Dulbecco\'s modified Eagle\'s medium (DMEM; Hyclone; GE Healthcare, Logan, UT, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone; GE Healthcare) and 1% penicillin and streptomycin at 37°C in an atmosphere containing 5% CO~2~.

### PA treatment

A solution of 10% (w/v) bovine serum albumin (BSA; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) was used to dissolve PA (Sigma-Aldrich; Merck KGaA) in order to obtain a final concentration of 0.3 mM. The autophagy inhibitor 3-methyladenine (3-MA; Selleck Chemicals, Houston, TX, USA) was dissolved in 0.3 mM PA at 1 M (PA+3-MA group) and NOX4 inhibitor GKT137831 (Selleck Chemicals) was dissolved in PA at 20 µM (PA+NOX4 inhibitor group). BSA (10%) alone was used as the vehicle control. All groups were treated at room temperature for 24 h.

### Cell viability assessment

Cell viability was assessed using Cell Counting Kit-8 (CCK-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan). Briefly, cells were seeded at density of 1×104 cells/well in 96-well plates. Cells were washed twice with PBS, following which CCK-8 reagent pre-mixed with DMEM at a ratio of 1:10 was added. Following incubation for 1 h, cell viability was measured by reading the absorbance at 450 nm on a microplate reader (EnVision XCite; PerkinElmer, Inc., Waltham, MA, USA).

### ROS assay

Intracellular ROS production was measured using a 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) assay according to the manufacturer\'s protocol (Beyotime Institute of Biotechnology, Haimen, China). Cells were washed thrice with serum-free DMEM, seeded in 6-well plates at a density of 2×105 cells/well and incubated for 30 min at 37°C with 1 ml DCFH-DA (1:1,000). Subsequently, cells were washed thrice with serum-free DMEM and observed under an inverted fluorescence microscope (Olympus Corp., Tokyo, Japan).

### Cytosolic Ca^2+^ measurement

Fura-2 acetoxymethyl (AM; Beyotime Institute of Biotechnology) was used to measure the cytosolic Ca^2+^ concentration. Briefly, cells were seeded in 96-well plates at a density of 1×104 cells/well and seeded with 2 µM Fura-2 AM diluted in Dulbecco\'s phosphate-buffered saline (DPBS). After incubation of 30 min, extracellular Fura-2 AM was then washed away three times by DPBS. Cellular fluorescence intensity measured at excitation wavelength of 340 and 380 nm. Cytosolic Ca^2+^ was expressed as the ratio of emitted fluorescence at 340 and 380 nm.

### Cell repair capability measurement

A scratch-wound healing assay was performed to assess the repair ability of endothelial cells. Briefly, cells were seeded in 6-well plates at a density of 2×105 cells/well marked with three equidistant parallel lines on the bottom of each well and starved for 24 h before the experiment. Subsequently, scratch wound was performed by a 10-µl max-volume pipette, the detached cells were washed away by DPBS. Three fields were selected for observation and imaging under a microscope (Olympus Corp.) when PA was added, images were taken and evaluated as 0 h. After PA treatment for 24 h, the same fields were assessed and marked as 24 h to evaluate the repair ability of endothelial cells.

### Nitric oxide (NO) assay

NO generation in HUVECs was measured using a Nitrate/Nitrite Assay kit (Beyotime Institute of Biotechnology). Initially, cells were treated with PA for 24 h in 6-well plates. Supernatants were collected after centrifugation for 5 min at 500 × g at room temperature for the NO assay (Beyotime Institute of Biotechnology). Nitrate/Nitrite Assay reagents was added into these supernatants according to the manufacturer\'s protocol. NO expression was estimated by measuring the absorbance at 540 nm.

### Matrigel tube formation assay

The formation of capillary-like structures by HUVECs was assessed using the Matrigel Basement Membrane Matrix (Corning Inc., Corning, NY, USA). Briefly, HUVECs were seeded in Matrigel-coated 96-well plates at a density of 5×104 cells/cm2. Tube formation was observed under an inverted phase fluorescent microscope (Olympus Corp.), and images were captured with a digital camera. The results were quantified by measuring the total length of the tubules in each well.

### Western blotting

Total protein was extracted from the cells using radioimmunoprecipitation assay buffer (Beyotime Institute of Biotechnology) and quantified by BCA (Beyotime Institute of Biotechnology). Equal amounts of cellular proteins (20 µg) were separated by SDS-PAGE on 10% gel and transferred to a polyvinylidene membrane. After blocking with 5% non-fat milk at room temperature for 2 h, the membranes were incubated overnight at 4°C with primary antibodies diluted at 1:1,000. The following primary antibodies were used: Light chain 3 (LC3; cat. no. 12741; Cell Signaling Technology, Inc., Danvers, MA, USA), PKCα (cat. no. sc-8393; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), p-PKCα (cat. no. sc-377565; Santa Cruz Biotechnology, Inc.), p62 (cat. no. sc-28359; Santa Cruz Biotechnology, Inc.), NOX4 (cat. no. ab133303; Abcam, Cambridge, UK) and GAPDH (diluted at 1:2,000; cat. no. sc-47724; Santa Cruz Biotechnology, Inc.). BeyoECL Plus (cat. no. P0018; Beyotime Institute of Biotechnology) was used and the detected bands were quantified by densitometric analysis and normalized to those of the corresponding loading control GAPDH using ImageJ software k 1.45 (National Institutes of Health, Bethesda, MD, USA).

### Transmission electron microscopy

Cells were harvested following 24 h of treatment, washed with 0.1 M cacodylate buffer (cat. no. 37238-25, Nacalai Tesque, Inc., Kyoto, Japan), fixed in 1% agarose in 0.1 M cacodylate buffer and then post-fixed in 1% osmium tetroxide (cat. no. 75632; Sigma-Aldrich; Merck KGaA) for 2 h. Following dehydration in serially diluted ethanol solutions, the cells were embedded in an epoxy resin. Ultrathin (60--80 nm) sections were cut and placed on the slides. The sections on the slides were then double stained with uranyl acetate and lead nitrate prior to examining under a transmission electron microscope (HT-7700; Hitachi, Ltd., Tokyo, Japan).

### Statistical analysis

Data were analyzed using IBM SPSS software (version 20.0; IBM Corp., Armonk, NY, USA) and are expressed as the mean ± standard error of the mean. Comparisons between multiple groups were assessed by Student-Newman-Keuls test, and P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### PA induces endothelial dysfunction in HUVECs

To assess whether ROS generation and the subsequent decrease in NO synthesis serve a critical role in the pathogenesis of endothelial dysfunction, ROS and NO production was assessed in HUVECs treated with 0.3 mM PA for 24 h. As expected, treatment with PA for 24 h resulted in a significant increase in ROS generation and decrease in NO synthesis as compared with those observed in the control group ([Fig. 1A-C](#f1-etm-0-0-7269){ref-type="fig"}). Cell viability was significantly decreased following PA treatment for 24 h, with \~60% of cells surviving ([Fig. 1D](#f1-etm-0-0-7269){ref-type="fig"}). In addition, the ability to form capillary-like structures, which is a crucial indicator of angiogenesis, was markedly reduced following PA treatment ([Fig. 1E and F](#f1-etm-0-0-7269){ref-type="fig"}). The repair ability of cells was also significantly suppressed by PA treatment, as observed by the reduced wound healing compared with the control group ([Fig. 1G and H](#f1-etm-0-0-7269){ref-type="fig"}).

### Autophagy inhibition decreases PA-induced ROS accumulation

To assess the effect of autophagy on ROS production, the autophagic activity was estimated by monitoring LC3 turnover and p62 degradation. The results were in agreement with previous observations ([@b17-etm-0-0-7269]). PA treatment was observed to significantly increase the LC3II/LC3I ratio ([Fig. 2A and B](#f2-etm-0-0-7269){ref-type="fig"}), markedly decrease p62 expression ([Fig. 2C and D](#f2-etm-0-0-7269){ref-type="fig"}) and significantly increase the number of autophagosomes ([Fig. 2E and F](#f2-etm-0-0-7269){ref-type="fig"}). However, these effects of PA were blocked by 3-MA, a specific autophagy inhibitor ([Fig. 2A-F](#f2-etm-0-0-7269){ref-type="fig"}). Furthermore, PA-induced ROS generation was significantly inhibited by 3-MA, suggesting that PA-induced ROS generation is autophagy-dependent ([Fig. 2G and H](#f2-etm-0-0-7269){ref-type="fig"}).

### PA-induced autophagy activates the Ca^2+^/PKCα/NOX4 pathway

NOX4 is an important source of intracellular ROS ([@b18-etm-0-0-7269]); therefore, the effect of PA-induced autophagy on NOX4 protein expression was assessed in the current study. NOX4 expression was significantly upregulated following PA treatment; however, treatment with the autophagy inhibitor 3-MA markedly blocked the PA-induced expression of NOX4 ([Fig. 3A and B](#f3-etm-0-0-7269){ref-type="fig"}). In order to explore the mechanism responsible for PA-induced NOX4 expression, the cytosolic Ca^2+^ concentration and PKCα expression were assessed using Fura-2 AM and western blotting analyses, respectively. The results revealed that cytosolic Ca^2+^ content was significantly increased in PA-treated cells compared with that in control cells, while 3-MA evidently reduced cytosolic Ca^2+^ ([Fig. 3C](#f3-etm-0-0-7269){ref-type="fig"}). Similarly, PKCα activation was upregulated following PA treatment, whereas it was significantly inhibited when 3-MA was also present in the culture medium ([Fig. 3D-F](#f3-etm-0-0-7269){ref-type="fig"}). These results suggest that PA-induced autophagy was able to activate the Ca^2+^/PKCα/NOX4 pathway.

### NOX4 inhibition improves PA-induced HUVEC dysfunction

To determine the role of PA-mediated activation of the Ca^2+^/PKCα/NOX4 pathway in endothelial dysfunction, the specific NOX4 inhibitor GKT137831 was used. The results revealed that GKT137831 significantly reduced PA-induced ROS generation ([Fig. 4A and B](#f4-etm-0-0-7269){ref-type="fig"}). Furthermore, NOX4 inhibition reversed the PA-induced decrease in NO synthesis, as indicated by the increased intracellular NO levels ([Fig. 4C](#f4-etm-0-0-7269){ref-type="fig"}). The PA-mediated damage in the formation of capillary-like structures was also alleviated by NOX4 inhibition ([Fig. 4D and E](#f4-etm-0-0-7269){ref-type="fig"}). Finally, the repair ability of cells was significantly improved, as indicated by a narrower scratch wound at 24 h in cells treated with a combination of PA and GKT137831, as compared with those treated with PA alone ([Fig. 4F and G](#f4-etm-0-0-7269){ref-type="fig"}). These results suggest that the PA-induced endothelial dysfunction is mediated through autophagy-dependent activation of the Ca^2+^/PKCα/NOX4 pathway.

Discussion
==========

In the present study a novel mechanism of PA-induced endothelial dysfunction in HUVECs was identified. Autophagy inhibition was demonstrated to downregulate PA-induced ROS generation by interfering with the Ca^2+^/PKCα/NOX4 pathway. Alleviating ROS and oxidative stress affects numerous signaling pathways associated with cell survival, proliferation, vasodilation (NO generation) and angiogenesis ([@b19-etm-0-0-7269]--[@b23-etm-0-0-7269]).

A number of studies have linked autophagic activity to ROS generation ([@b24-etm-0-0-7269]--[@b26-etm-0-0-7269]). Generally, ROS activates autophagy, which inhibits excessive ROS generation in a negative feedback manner. ROS accumulation promotes autophagic activity via multiple mechanisms, including activation of adenosine 5′-monophosphate-activated protein kinase ([@b27-etm-0-0-7269]), promotion of high mobility group box 1 translocation from the nucleus to the cytoplasm ([@b28-etm-0-0-7269],[@b29-etm-0-0-7269]), and stabilization of hypoxia-inducible factor-1α ([@b30-etm-0-0-7269],[@b31-etm-0-0-7269]). ROS-induced activation of autophagy clears damaged mitochondria and subsequently decreases ROS generation ([@b24-etm-0-0-7269]). Conversely, it has been reported that autophagy promotes ROS generation rather than suppressing it ([@b16-etm-0-0-7269]). In the present study, PA-induced ROS generation was significantly decreased when cells were simultaneously treated with an inhibitor, suggesting that autophagy possibly regulates ROS production. Based on these findings, the mechanism by which autophagy may promote ROS production was further explored, and it was demonstrated that 3-MA treatment reduced PA-induced cytosolic Ca^2+^ upregulation. Given that elevated cytosolic Ca^2+^ concentrations have been reported to activate NOXs via PKC activation ([@b32-etm-0-0-7269]), PKCα activation and NOX4 expression were examined in cells treated with PA and/or 3-MA. The results revealed that the inhibition of autophagy significantly decreased the PA-induced expression levels of p-PKCα and NOX4. Although NOX4 has been reported to activate phosphoinositide 3-kinase ([@b33-etm-0-0-7269]), 3-MA still effectively inhibited autophagy in HUVECs, as illustrated by the western blotting and electron microscopy results in the current study. In addition, using the specific NOX4 inhibitor GKT137831, it was confirmed that NOX4 suppression improved PA-induced endothelial dysfunction. Taken together, these findings suggest that PA-induced ROS generation is achieved by activation autophagy via the Ca^2+^/PKCα/NOX4 pathway.

In conclusion, the results of the present study suggested that PA-induced autophagy activates the Ca^2+^/PKCα/NOX4 pathway to promote ROS generation. The novel pathway identified in the present study may help to improve our understanding of PA lipotoxicity, therefore providing a novel strategy that may have potential as a treatment for CVDs caused by hypertriglyceridemia.
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![PA induces endothelial dysfunction in human umbilical vein endothelial cells (magnification, ×400). Cells were treated with 10% BSA as a vehicle control or 0.3 mM PA for 24 h. (A) Representative fluorescence microscopy imaging and (B) quantitative analysis of reactive oxygen species generation. (C) Quantitative analysis of NO generation as assessed using a Nitrate/Nitrite assay kit. (D) Quantitative analysis of cell viability as assessed using a Cell Counting Kit-8 assay. (E) Representative imaging and (F) quantitative analysis of the capillary-like structure formation. (G) Representative wound healing assay images and (H) quantitative analysis of the repair ability of cells. Data are presented as the mean ± standard error of the mean of three independent experiments. \*P\<0.05 vs. vehicle control. PA, palmitic acid; BSA, bovine serum albumin; NO, nitric oxide.](etm-17-04-2425-g00){#f1-etm-0-0-7269}

![Inhibiting autophagy decreases PA-induced ROS accumulation. Human umbilical vein endothelial cells were treated with 0.3 mM PA alone or PA + 1 mM 3-MA for 24 h. BSA was used as the vehicle control. (A) Representative western blot images and (B) quantitative analysis of LC3 expression. (C) Representative western blot images and (D) quantitative analysis of p62 expression. (E) Representative electron microscope images and (F) quantitative analysis of autophagosomes in cells following treatment (arrows indicate autophagosomes). (G) Representative fluorescence assay images and (H) quantitative analysis of intracellular ROS generation. Data are presented as the mean ± standard error of the mean of three independent experiments. \*P\<0.05 vs. vehicle control; \#P\<0.05 vs. PA. PA, palmitic acid; ROS, reactive oxygen species; 3-MA, 3-methyladenine; BSA, bovine serum albumin; LC3, light chain 3; LM, local magnification.](etm-17-04-2425-g01){#f2-etm-0-0-7269}

![PA-induced autophagy activates the Ca^2+^/PKCα/NOX4 pathway. Human umbilical vein endothelial cells were treated with 0.3 mM PA alone or PA + 1 mM 3-MA for 24 h. BSA was used as a vehicle control. (A) NOX4 protein expression was measured using western blotting, and (B) quantitative analysis of protein levels is shown. (C) Cytosolic Ca^2+^ levels were measured using Fura-2 AM, and the ratios of fluorescence intensity of Fura-2 AM at 340/380 nm were calculated. (D) Quantitative analysis and (E) representative western blots of PKCα expression. (F) Quantitative analysis of PKCα phosphorylate ratio. Data are presented as the mean ± standard error of the mean of three independent experiments. \*P\<0.05 vs. vehicle control; \#P\<0.05 vs. PA. PA, palmitic acid; 3-MA, 3-methyladenine; Ca^2+^/PKCα/NOX4, calcium ion/protein kinase Cα/nicotinamide adenine dinucleotide phosphate oxidase 4; BSA, bovine serum albumin; AM, acetoxymethyl.](etm-17-04-2425-g02){#f3-etm-0-0-7269}

![NOX4 inhibition ameliorated PA-induced HUVEC dysfunction (magnification, ×400). HUVECs were treated with 0.3 mM PA in the presence or absence of 20 µM GKT137831. BSA was used as a vehicle control. (A) Reactive oxygen species production was measured by assessing the cell fluorescence in a given area, and (B) quantitative analysis of the results is shown. (C) NO production was measured using a commercial Nitrate/Nitrite assay kit. (D) Representative imaging and (E) quantitative analysis of the capillary-like structure formation of cells. (F) Representative wound healing images and (G) quantitative analysis of the repair ability of cells. Data are presented as the mean ± standard error of the mean of three independent experiments. \*P\<0.05 vs. vehicle control; \#P\<0.05 vs. PA. NOX4, nicotinamide adenine dinucleotide phosphate oxidase 4; PA, palmitic acid; HUVEC, human umbilical vein endothelial cell; BSA, bovine serum albumin; NO, nitric oxide.](etm-17-04-2425-g03){#f4-etm-0-0-7269}
